Unlocking the potential of solid samples in the field of biological diagnostic Diagante develops a solution for in vitro diagnostics. Its platform allows the analysis of solid clinical specimen on rapid and high throughput instruments in clinical pathology labs. It provides faster results, enhanced personalized medical care, and lower costs to the stakeholders.

75 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Innovation for Biotherapies BIOSYNEX was founded in 2005 and is one of the most significant European manufacturers and provider of rapid membrane tests in the in-vitro diagnostic market. By staying close to our customers and business partners we are aware of the needs and expectations they may have of our products and services. Listening to their voice, together with the help of our Research and Development laboratories in France and our state of the art manufacturing facilities, allows us to identify new applications in rapid testing, develop and launch innovative products and provide high quality services. Our aim is to …

110 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Reinvent monitoring of patients under anticancer #Akoadom, continuum+ Connect remote monitoring platform Closer to patients. Cancer, health, digital, e-health, home support, and Télésuivi

266 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

PROTEIGENE (https://proteigene.com/) deals with scientific products and technologies since 1999. During more than 20 years, we delivered high level technology systems like Qbot/Qpix, Clonepix FL, Fragment analyzer, ImageStreamX , SeaHorse analysers and many others. Today, we still propose powerfull systems and consummables in Single Cell Analysis, Cell line development and Antibody research, Numeric NGS, Multi Omics plateform , targeted metabolomics, lab in a cell devices... Cyto-Mine by Sphere Fluidics, GenapSys, A4Cell technology Biocrates kits Sengenics Immunoprofiling services Robotics S-LAb from PAA and others. https://proteigene.com/ Biologie Moléculaire, Biologie Cellulaire, Métabolomique, Proteomique, Single cell Analysis, and NGS

61 similar entities Type: SMB Activities: deeptech biotech Technologies: Robotics

LGC Clinical Diagnostics | Science for a Safer World Technopath Clinical Diagnostics is a global leader in the development, manufacturing and delivery of high quality independent quality controls and QC data management software for the In-Vitro Diagnostics industry. Our customers include hospitals, clinical laboratories, research facilities, CROs and blood banks in over 120 countries globally. Our partners equally are the leading innovators of clinical diagnostics instruments and systems and we collaborate with the most experienced academic institutions and reference laboratories in our research and development activities. In February 2021, Technopath joined LGC Clinical Diagnostics, a leading in vitro diagnostic (IVD) …

25 similar entities Type: SMB Activities: biotech deeptech Technologies: Data Analytics

Biosensorix is a privately held diagnostic company that provides affordable tools enabling fast and accurate life-saving decisions. The company is focused on bringing quantitation to rapid point-of-care testing, allowing earlier and precise treatment that will benefit patients in developing countries and worldwide. The initial technologies target dengue diagnosis and will extend to disease marker detection areas where quantitation is vital and currently unmet. Established in November 2015, Biosensorix is a spin-off from the collaboration between Ben Gurion University of the Negev (Israel) and Nanyang Technological University (Singapore) under the NEW CREATE program in Singapore. The impact and platform success led …

4 similar entities Type: Startup Activities: deeptech Technologies: SaaS

Developing novel IVD solutions Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals. Biotechnology, Genetik …

165 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Discovery Fueled by Ultra-Sensitivity Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognosis and precise treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research …

92 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Disease Diagnostic Group, Inc is focused on screening, tracking, and diagnosing highly infectious or neglected tropical diseases through portable and reusable devices. Medical Device Design, Malaria, Infectious Disease, and Diagnostics

132 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Explorers on the frontier of life-changing science. NGM Bio is a biopharmaceutical company focused on discovering and developing novel, life-changing medicines for people whose health and lives have been disrupted by disease. The company’s biology-centric drug discovery approach aims to seamlessly integrate interrogation of complex disease-associated biology and protein engineering expertise to unlock proprietary insights that are leveraged to generate promising product candidates and enable their rapid advancement into proof-of-concept studies. As explorers on the frontier of life-changing science, NGM Bio aspires to operate one of the most productive research and development engines in the biopharmaceutical industry. All therapeutic candidates …

53 similar entities Type: Startup Activities: biotech manufacturing deeptech Technologies: Synthetic Biology

Bioinnovation at your service. Biomedal S.L is a biotechnology company whose mission is to develop and commercialize new technologies, services and products for research, bioindustry and diagnostics. The company develops its activities in two areas: Biomedal Life Sciences and Biomedal Diagnostics. Biomedal Life Science is devoted to the development and commercialization of products and services for life sciences research, and technology for industrial bioprocesses. Its own technology allowed the improvement of recombinant protein production.Biomedal Life Science also functions as a CRO (Contract Research Organization) and provides services and support to pharmaceutical or biotechnology companies. Biomedal Diagnostics offers a large variety …

101 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes in patient management. The Company uses its expertise in antibodies and assay development, as well as its platform for assay development, to create a pipeline of novel and compelling products that focus on conditions where there is significant unmet medical need, and where the Company’s tests can help improve clinical and economic outcomes for patients, providers, and the healthcare ecosystem. The Company’s flagship products, ProNephro AKITM and The NGAL TestTM, are based …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Let's Build Better Cells Together We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERTTM platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATxTM, STxTM, GTxTM and VLx TM; a portfolio of proprietary related processing assemblies or disposables; and software protocols, …

315 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology